Bicara Therapeutics Inc. (BCAX) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Bicara Therapeutics Second Quarter twenty twenty six Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there'll be a question and answer session. To ask a question during the session, you'll need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To answer your question, please press 11 again. Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker for today, Rachel Frank. Please go ahead. Thank you, and good morning, everyone. It's a pleasure to welcome you to Bicara Therapeutics second quarter twenty twenty six earnings call. Earlier this morning, we issued a press release highlighting results from the quarter and provided a business update, including strategic leadership transitions marking the company's next era of growth and execution. You can access the press release as well as the slides that we'll be reviewing today by going to the Investors section of our company website. Before we begin, please note that this call will include forward looking statements under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Please refer to our most recent SEC filings for important risk factors that could cause our actual performance and results to materially differ from those expressed or implied in these forward looking statements. Any forward looking statement made on this call represents our views only as of today, and we disclaim any obligation to update any forward looking statements. Joining us on the call today are Claire Mazumdar, Chief Executive Officer Ryan Colgey, President and Chief Operating ...